Health Care: Drugs

Momenta Pharmaceuticals Inc (MNTA: NASDAQ)

$17.3 -0.35 | -1.98%
06/29/17 - 12:16 PM ET
Company Profile
Price and Volume
Recent Price 17.65
52 Week High 19.90
52 Week Low 10.50
Avg. Daily Vol. (Mil) 0.84
Beta (3 year) 2.02
Share Related Items
Mkt Cap (Mil) 1,309.60
Shares Out (Mil) 74.20
Float (Mil) 53.71
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.00
Current Ratio 4.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 11.25
Price/Book 3.54
Price/Cash Flow -65.90
Per Share Data
Earnings -0.43
Sales 1.57
Book Value 4.99
Cash Flow -0.27
Business Summary
Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.
General Information
675 West Kendall Street
Cambridge, MA 02142
Industry : Drugs
Sector: Health Care
Employees: 290
CEO: Craig A. Wheeler
Short Interest
Current Month (Mil) 4.99
Previous Month (Mil) 5.04
Short Interest Ratio (Days) 5.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -5.50
Return on Investments -7.80
Gross Margin n.a.
EBIT Margin -32.30
Profit Margin -24.70

Portfolios with MNTA

Latest MNTA Headlines from TheStreet

More Financial News for MNTA

Press Releases for MNTA

See All Press Releases

Partner Headlines for MNTA

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter